Utilisation des AINS et des antalgiques chez les patients ayant une spondyloarthrite sous biothérapie. Données du registre de biothérapie de la Société Marocaine de rhumatologie (RBSMR)
Anass Kherrab(Hôpital Militaire Avicenne), R. Niamane(Hôpital Militaire Avicenne), L. Achemlal, I. Ghozlani(Régie Autonome Multi Services D'Agadir), H. Hassikou, R. Bahiri(Centre Hospitalier Universitaire de Rabat-Salé), F. Allali(Délégation Paris 5), A. El Maghraoui, I. Chergaoui(Cadi Ayyad University), Rédouane Abouqal(Mohammed V University), Ihsane Hmamouchi(International University of Rabat), Hanane Chitachen(Cadi Ayyad University), Toufik Harzy(Centre Hospitalier Universitaire Hassan II), Ouafae Mkinsi(Centre Hospitalier Universitaire Ibn Rochd), Mirieme Ghazi(Cadi Ayyad University), I. El Bouchti, L. Ichchou(Hôpital El Ayachi)
Cited by 2
Related Papers
Why we should definitely include intra-articular hyaluronic acid as a therapeutic option in the management of knee osteoarthritis: Results of an extensive critical literature review
|Seminars in Arthritis and Rheumatism|2018|164
High Prevalence of Hypovitaminosis D in Morocco: Relationship to Lifestyle, Physical Performance, Bone Markers, and Bone Mineral Density
|Seminars in Arthritis and Rheumatism|2008|154
Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor α
|Annals of the Rheumatic Diseases|2003|122
Sarcopenia in rheumatoid arthritis: prevalence, influence of disease activity and associated factors
|Rheumatology International|2017|114